A081801
OPEN TO ACCRUAL
Ph 3 Study of Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC
UW25019
OPEN TO ACCRUAL
HEARTS - Cardiac Radiation Therapy Sparing for Thoracic Cancers Phase II
UW25134
OPEN TO ACCRUAL
Ph 3 Study of Efficacy and Safety of Olomorasib in Combo with SOC in patients with KRAS G12C NSCLC